TMEM60
gene geneOn this page
Also known as DC32
Summary
TMEM60 (transmembrane protein 60, HGNC:21754) is a protein-coding gene on chromosome 7q11.23, encoding Transmembrane protein 60 (Q9H2L4).
Predicted to be located in membrane.
Source: NCBI Gene 85025 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 23 total
- MANE Select transcript:
NM_032936
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21754 |
| Approved symbol | TMEM60 |
| Name | transmembrane protein 60 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DC32 |
| Ensembl gene | ENSG00000135211 |
| Ensembl biotype | protein_coding |
| Entrez | 85025 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000257663, ENST00000858200, ENST00000926858, ENST00000926859, ENST00000926860, ENST00000968240
RefSeq mRNA: 1 — MANE Select: NM_032936
NM_032936
CCDS: CCDS5593
Canonical transcript exons
ENST00000257663 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001090748 | 77798254 | 77798434 |
| ENSE00001428380 | 77793728 | 77794423 |
Expression profiles
Bgee: expression breadth ubiquitous, 254 present calls, max score 99.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.1578 / max 283.0321, expressed in 1803 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 84473 | 23.1578 | 1803 |
Top tissues by expression
257 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 99.50 | gold quality |
| oocyte | CL:0000023 | 98.54 | gold quality |
| ileal mucosa | UBERON:0000331 | 95.53 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.38 | gold quality |
| tibialis anterior | UBERON:0001385 | 93.87 | gold quality |
| monocyte | CL:0000576 | 92.90 | gold quality |
| leukocyte | CL:0000738 | 92.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.61 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.60 | gold quality |
| pancreatic ductal cell | CL:0002079 | 92.11 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 91.98 | gold quality |
| upper arm skin | UBERON:0004263 | 91.23 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 91.11 | gold quality |
| retina | UBERON:0000966 | 91.09 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 91.03 | gold quality |
| rectum | UBERON:0001052 | 90.55 | gold quality |
| deltoid | UBERON:0001476 | 90.55 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.43 | gold quality |
| calcaneal tendon | UBERON:0003701 | 90.28 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.25 | gold quality |
| kidney epithelium | UBERON:0004819 | 90.24 | silver quality |
| granulocyte | CL:0000094 | 90.05 | gold quality |
| adult organism | UBERON:0007023 | 90.05 | gold quality |
| pancreas | UBERON:0001264 | 89.97 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.74 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 89.54 | gold quality |
| sperm | CL:0000019 | 89.48 | silver quality |
| lymph node | UBERON:0000029 | 89.37 | gold quality |
| metanephros | UBERON:0000081 | 89.27 | gold quality |
| parietal pleura | UBERON:0002400 | 89.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.69 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting TMEM60, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-3120-3P | 99.54 | 70.28 | 2669 |
| HSA-MIR-105-5P | 99.54 | 69.24 | 2060 |
| HSA-MIR-7853-5P | 99.54 | 69.30 | 2055 |
| HSA-MIR-4728-3P | 99.47 | 68.94 | 981 |
| HSA-MIR-653-5P | 99.46 | 67.35 | 1300 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-4635 | 98.74 | 67.63 | 1339 |
| HSA-MIR-6764-3P | 98.44 | 67.64 | 1153 |
| HSA-MIR-6824-3P | 98.44 | 67.62 | 1154 |
| HSA-MIR-4277 | 98.34 | 67.17 | 1323 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-4695-3P | 96.71 | 67.21 | 836 |
| HSA-MIR-3976 | 96.67 | 67.79 | 1187 |
| HSA-MIR-563 | 96.26 | 66.13 | 450 |
| HSA-MIR-4774-5P | 95.92 | 68.27 | 827 |
| HSA-MIR-380-5P | 95.68 | 67.32 | 512 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem60 | ENSMUSG00000045435 |
| rattus_norvegicus | Tmem60 | ENSRNOG00000013510 |
| drosophila_melanogaster | CG13919 | FBGN0035248 |
Paralogs (2): TMEM185B (ENSG00000226479), TMEM185A (ENSG00000269556)
Protein
Protein identifiers
Transmembrane protein 60 — Q9H2L4 (reviewed: Q9H2L4)
All UniProt accessions (1): Q9H2L4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_116325* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019396 | TM_Fragile-X-F-assoc | Family |
Pfam: PF10269
UniProt features (6 total): transmembrane region 4, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H2L4-F1 | 77.43 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 88 (showing top):
RNGTGGGC_UNKNOWN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN, chr7q11, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, STAT5A_01, MYB_Q6, TCANNTGAY_SREBP1_01, DELACROIX_RAR_BOUND_ES, FORTSCHEGGER_PHF8_TARGETS_DN, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, GREB1_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
498 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM60 | TVP23B | Q9NYZ1 | 687 |
| TMEM60 | FAM229B | Q4G0N7 | 569 |
| TMEM60 | WDR37 | Q9Y2I8 | 559 |
| TMEM60 | TMEM120A | Q9BXJ8 | 506 |
| TMEM60 | WDR72 | Q3MJ13 | 504 |
| TMEM60 | TMEM120B | A0PK00 | 495 |
| TMEM60 | ANXA9 | O76027 | 480 |
| TMEM60 | SLC6A13 | Q9NSD5 | 448 |
| TMEM60 | PHTF2 | Q8N3S3 | 433 |
| TMEM60 | NPIPB9 | F8W1W9 | 420 |
| TMEM60 | ANKRD65 | E5RJM6 | 419 |
| TMEM60 | TFDP2 | Q14188 | 412 |
| TMEM60 | TMEM236 | Q5W0B7 | 405 |
| TMEM60 | SLC22A2 | O15244 | 404 |
| TMEM60 | ZNF570 | Q96NI8 | 380 |
IntAct
296 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM60 | GPR61 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | HSD17B11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | ERVFRD-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | SLC6A15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | LEPROTL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | IL10RA | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | SLC39A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | IL7R | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | SAR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | ANKS6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | LRRC3B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | CPLX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | SPNS3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | LHFPL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | PAGE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | GJA8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM60 | SCN3B | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (91): TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid), TMEM60 (Two-hybrid)
ESM2 similar proteins: A0A078H868, B3Y064, B9RK42, B9TRX0, O14038, O15243, O65085, O76767, O89013, P38312, P48583, P49858, P52159, P53173, Q09473, Q0DET3, Q0IHJ0, Q0VGV9, Q22361, Q28FY5, Q2QQ55, Q3EDD7, Q3SYT0, Q3ZBX1, Q561T9, Q5F433, Q5PR61, Q5PSV5, Q5XH84, Q5ZJD9, Q658I5, Q66I08, Q6DGL7, Q6GNX5, Q6PFS5, Q7SYR6, Q84W04, Q8GWT5, Q8K174, Q8R1L4
Diamond homologs: Q8K174, Q9H2L4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 95 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| R-HSA-425366 | 5 | 18.1× | 4e-04 |
| SLC-mediated transmembrane transport | 8 | 9.5× | 1e-04 |
| Transport of small molecules | 13 | 6.5× | 8e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| transmembrane transport | 5 | 9.8× | 9e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
472 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:77798970:CGGTA:C | donor_loss | 0.9900 |
| 7:77798971:GGTAA:G | donor_loss | 0.9900 |
| 7:77798972:G:GG | donor_gain | 0.9900 |
| 7:77798972:G:T | donor_loss | 0.9900 |
| 7:77798973:T:G | donor_loss | 0.9900 |
| 7:77794404:C:CT | acceptor_gain | 0.9800 |
| 7:77794422:CC:C | acceptor_gain | 0.9800 |
| 7:77794423:CC:C | acceptor_gain | 0.9800 |
| 7:77797455:A:C | donor_gain | 0.9800 |
| 7:77798249:CTCA:C | donor_loss | 0.9800 |
| 7:77798250:TCA:T | donor_loss | 0.9800 |
| 7:77798251:CAC:C | donor_loss | 0.9800 |
| 7:77798252:ACCT:A | donor_loss | 0.9800 |
| 7:77799042:G:GT | donor_gain | 0.9700 |
| 7:77799233:TCCTC:T | donor_gain | 0.9700 |
| 7:77794405:G:T | acceptor_gain | 0.9600 |
| 7:77797454:A:AC | donor_gain | 0.9500 |
| 7:77798388:T:TA | donor_gain | 0.9500 |
| 7:77798399:T:TA | donor_gain | 0.9500 |
| 7:77799058:G:GT | donor_gain | 0.9500 |
| 7:77799059:G:T | donor_gain | 0.9500 |
| 7:77794424:CT:C | acceptor_loss | 0.9400 |
| 7:77794425:T:G | acceptor_loss | 0.9400 |
| 7:77798248:ACTC:A | donor_loss | 0.9400 |
| 7:77798252:A:AC | donor_gain | 0.9400 |
| 7:77798253:C:CC | donor_gain | 0.9400 |
| 7:77794420:TACC:T | acceptor_gain | 0.9300 |
| 7:77794426:A:C | acceptor_loss | 0.9200 |
| 7:77799002:GGGC:G | donor_gain | 0.9100 |
| 7:77798253:CCTGG:C | donor_gain | 0.9000 |
AlphaMissense
862 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:77794247:A:G | W43R | 0.996 |
| 7:77794247:A:T | W43R | 0.996 |
| 7:77794337:A:G | W13R | 0.995 |
| 7:77794337:A:T | W13R | 0.995 |
| 7:77794252:G:T | P41Q | 0.993 |
| 7:77794252:G:C | P41R | 0.992 |
| 7:77794034:A:G | W114R | 0.991 |
| 7:77794034:A:T | W114R | 0.991 |
| 7:77794271:A:G | W35R | 0.991 |
| 7:77794271:A:T | W35R | 0.991 |
| 7:77794039:G:C | P112R | 0.990 |
| 7:77794039:G:T | P112H | 0.988 |
| 7:77794104:G:C | F90L | 0.988 |
| 7:77794104:G:T | F90L | 0.988 |
| 7:77794106:A:G | F90L | 0.988 |
| 7:77794237:T:A | D46V | 0.987 |
| 7:77794261:A:T | I38K | 0.986 |
| 7:77794019:C:G | G119R | 0.985 |
| 7:77794019:C:T | G119R | 0.985 |
| 7:77794237:T:G | D46A | 0.985 |
| 7:77794243:A:T | I44K | 0.985 |
| 7:77794090:C:T | C95Y | 0.983 |
| 7:77794089:A:C | C95W | 0.982 |
| 7:77794238:C:G | D46H | 0.981 |
| 7:77794091:A:G | C95R | 0.980 |
| 7:77794018:C:T | G119E | 0.979 |
| 7:77794093:A:T | L94H | 0.979 |
| 7:77794294:A:G | L27P | 0.977 |
| 7:77794253:G:A | P41S | 0.976 |
| 7:77794296:T:A | K26N | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000437122 (7:77797066 C>A), RS1001528735 (7:77793445 T>C), RS1002109094 (7:77798689 C>T), RS1002131340 (7:77795473 C>T), RS1002526919 (7:77795093 G>A), RS1002589054 (7:77795708 T>G), RS1002661115 (7:77795406 T>C), RS1003012796 (7:77796899 A>G), RS1004267015 (7:77793334 A>C,T), RS1004445909 (7:77799509 C>G,T), RS1004739143 (7:77793550 C>T), RS1005401260 (7:77796748 C>G), RS1005495726 (7:77794681 G>C), RS1005555974 (7:77800024 G>A), RS1006405913 (7:77795337 T>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000649_15 | Chronic kidney disease | 2.000000e-09 |
| GCST003372_19 | Glomerular filtration rate (creatinine) | 8.000000e-13 |
| GCST003401_18 | Glomerular filtration rate in non diabetics (creatinine) | 1.000000e-12 |
| GCST004292_46 | Glomerular filtration rate (creatinine) | 1.000000e-09 |
| GCST007344_73 | Estimated glomerular filtration rate | 1.000000e-15 |
| GCST008058_169 | Estimated glomerular filtration rate | 2.000000e-36 |
| GCST008061_3 | Estimated glomerular filtration rate | 3.000000e-06 |
| GCST008745_65 | Estimated glomerular filtration rate in non-diabetics | 6.000000e-15 |
| GCST008747_28 | Estimated glomerular filtration rate | 2.000000e-23 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance | 3 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| potassium chromate(VI) | decreases expression, affects cotreatment | 1 |
| beta-methylcholine | affects expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Cadmium | decreases expression | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Silver | decreases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.